Micro-X Ltd - Asset Resilience Ratio
Micro-X Ltd (MX1) has an Asset Resilience Ratio of 28.12% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Micro-X Ltd (MX1) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Micro-X Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of Micro-X Ltd for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Micro-X Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Micro-X Ltd market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$4.90 Million | 28.12% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$4.90 Million | 28.12% |
Asset Resilience Insights
- Very High Liquidity: Micro-X Ltd maintains exceptional liquid asset reserves at 28.12% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Micro-X Ltd Industry Peers by Asset Resilience Ratio
Compare Micro-X Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 9.40% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Ok Biotech Co Ltd
TW:4155 |
Medical Devices | 0.32% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Micro-X Ltd (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Micro-X Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 14.67% | AU$3.24 Million ≈ $2.29 Million |
AU$22.11 Million ≈ $15.64 Million |
+2.66pp |
| 2024-06-30 | 12.00% | AU$3.23 Million ≈ $2.28 Million |
AU$26.89 Million ≈ $19.03 Million |
-5.24pp |
| 2023-06-30 | 17.24% | AU$5.22 Million ≈ $3.70 Million |
AU$30.30 Million ≈ $21.44 Million |
-15.70pp |
| 2022-06-30 | 32.94% | AU$10.30 Million ≈ $7.29 Million |
AU$31.28 Million ≈ $22.13 Million |
-34.50pp |
| 2021-06-30 | 67.44% | AU$30.14 Million ≈ $21.32 Million |
AU$44.68 Million ≈ $31.61 Million |
+13.09pp |
| 2020-06-30 | 54.35% | AU$18.32 Million ≈ $12.96 Million |
AU$33.70 Million ≈ $23.85 Million |
+38.08pp |
| 2019-06-30 | 16.27% | AU$1.61 Million ≈ $1.14 Million |
AU$9.87 Million ≈ $6.98 Million |
-11.52pp |
| 2018-06-30 | 27.79% | AU$4.07 Million ≈ $2.88 Million |
AU$14.65 Million ≈ $10.37 Million |
+6.09pp |
| 2017-06-30 | 21.70% | AU$5.58 Million ≈ $3.95 Million |
AU$25.70 Million ≈ $18.19 Million |
-- |
About Micro-X Ltd
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or … Read more